EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Safety and Efficacy of Mosunetuzumab: Experience in the Hospital Cardinale Giovanni Panico

Giulio Turco, Donatella Tarantino, Antonietta Giuseppa Ferraro, Giuseppina Greco, Domenico Tricarico iD

Antibodies · 13.05.2026 · 15 (3) · 40

DOI: 10.3390/antib15030040 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Antibodies, online erschienen am 13.05.2026. Verfasst von Giulio Turco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Operative Complex Unit of Hospital Pharmacy Pia Fondazione di Culto e Religione Card. G. Panico, 73039 Tricase, Italy. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Follicular lymphoma (FL) is one of the most common indolent B-cell non-Hodgkin lymphomas (NHL) and is characterized by recurrent relapses despite advances in therapy. Bispecific antibodies that redirect T lymphocytes toward malignant B cells represent a major innovation in the treatment of relapsed or refractory disease. Mosunetuzumab is a CD20×CD3 bispecific antibody that induces T-cell mediated cytotoxicity against B-cell malignancies. In this manuscript, we describe the clinical experience with mosunetuzumab in three patients with relapsed or refractory FL treated at the Hospital Card. G. Panico, Tricase (LE).

Methods

Clinical history, prior therapies, treatment responses, and safety outcomes are reported.

Results

The cases illustrate the potential efficacy and manageable safety profile of mosunetuzumab in heavily pretreated FL patients.

Conclusion

The effectiveness of this drug is confirmed in our center.

Schlagwörter

Stichwörter der Autor:innen

CD20CD3bispecific antibodiesfollicular lymphomaimmunotherapymosunetuzumabrelapsed lymphoma

Autor:innen und Institutionen

  • Operative Complex Unit of Hospital Pharmacy Pia Fondazione di Culto e Religione Card. G. Panico, 73039 Tricase, Italy.
  • Operative Complex Unit of Hematology Pia Fondazione di Culto e Religione Card. G. Panico, 73039 Tricase, Italy.
  • Hospital School of Pharmacy, Department of Pharmacy, Pharmaceutical Sciences, University of Bari Aldo Moro, 70125 Bari, Italy.

ORCID-Profile: Domenico Tricarico

Zitieren

APA

Turco, G., Tarantino, D., Ferraro, A. G., Greco, G., & Tricarico, D. (2026). Safety and Efficacy of Mosunetuzumab: Experience in the Hospital Cardinale Giovanni Panico. Antibodies, 15(3), 40. https://doi.org/10.3390/antib15030040

Vancouver

Turco G, Tarantino D, Ferraro AG, Greco G, Tricarico D. Safety and Efficacy of Mosunetuzumab: Experience in the Hospital Cardinale Giovanni Panico. Antibodies. 2026;15(3):40. doi:10.3390/antib15030040

BibTeX
@article{Turco2026,
  author = {Turco, Giulio and Tarantino, Donatella and Ferraro, Antonietta Giuseppa and Greco, Giuseppina and Tricarico, Domenico},
  title = {Safety and Efficacy of Mosunetuzumab: Experience in the Hospital Cardinale Giovanni Panico},
  journal = {Antibodies},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {40},
  doi = {10.3390/antib15030040}
}
Kostenlos starten →